Compumedics Limited (ASX:CMP)
Australia
· Delayed Price · Currency is AUD 0.2750
+0.0150 (5.77%)
May 7, 2025, 3:40 PM AEST
Compumedics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 46.83 | 49.72 | 42.41 | 37.76 | 35.74 | 35.07 | Upgrade
|
| Other Revenue | 0.54 | 0.54 | 0.52 | 0.85 | - | - | Upgrade
|
| Revenue | 47.37 | 50.26 | 42.92 | 38.61 | 35.74 | 35.07 | Upgrade
|
| Revenue Growth (YoY) | -5.50% | 17.10% | 11.18% | 8.02% | 1.91% | -15.51% | Upgrade
|
| Cost of Revenue | 22.45 | 23.65 | 20.82 | 18.44 | 16.58 | 17.06 | Upgrade
|
| Gross Profit | 24.92 | 26.61 | 22.11 | 20.17 | 19.16 | 18.01 | Upgrade
|
| Selling, General & Admin | 23.21 | 21.14 | 19.66 | 15.13 | 14.38 | 14.93 | Upgrade
|
| Research & Development | 2.4 | 5.74 | 5.46 | 4.06 | 4.39 | 3.84 | Upgrade
|
| Other Operating Expenses | -0.2 | - | - | - | -0.56 | -0.36 | Upgrade
|
| Operating Expenses | 25.4 | 26.88 | 25.12 | 19.18 | 18.21 | 18.41 | Upgrade
|
| Operating Income | -0.48 | -0.27 | -3.02 | 0.99 | 0.96 | -0.4 | Upgrade
|
| Interest Expense | -0.87 | -0.74 | -0.65 | -0.4 | -0.33 | -0.42 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | -0.18 | 0.04 | 0.17 | -0.81 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | -1.3 | -1.19 | -3.63 | 0.76 | -0.18 | -0.75 | Upgrade
|
| Asset Writedown | -0 | 1.67 | -3.09 | - | - | -7.66 | Upgrade
|
| Other Unusual Items | - | - | - | 0.94 | 0.96 | 0.91 | Upgrade
|
| Pretax Income | -1.3 | 0.48 | -6.72 | 1.7 | 0.78 | -7.5 | Upgrade
|
| Income Tax Expense | 0.29 | 0.82 | -0.6 | 0.34 | -0.22 | -1.67 | Upgrade
|
| Net Income | -1.59 | -0.34 | -6.12 | 1.36 | 1 | -5.84 | Upgrade
|
| Net Income to Common | -1.59 | -0.34 | -6.12 | 1.36 | 1 | -5.84 | Upgrade
|
| Net Income Growth | - | - | - | 35.97% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 199 | 177 | 177 | 177 | 177 | 177 | Upgrade
|
| Shares Outstanding (Diluted) | 199 | 177 | 177 | 177 | 177 | 177 | Upgrade
|
| Shares Change (YoY) | 24.92% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 | -0.03 | Upgrade
|
| EPS Growth | - | - | - | 35.97% | - | - | Upgrade
|
| Free Cash Flow | -1.57 | 1.69 | -0.88 | 2.67 | 1.16 | 4.98 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.01 | -0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Gross Margin | 52.61% | 52.94% | 51.50% | 52.25% | 53.62% | 51.36% | Upgrade
|
| Operating Margin | -1.01% | -0.53% | -7.03% | 2.56% | 2.68% | -1.14% | Upgrade
|
| Profit Margin | -3.36% | -0.67% | -14.26% | 3.52% | 2.79% | -16.65% | Upgrade
|
| Free Cash Flow Margin | -3.31% | 3.36% | -2.04% | 6.92% | 3.25% | 14.20% | Upgrade
|
| EBITDA | 0.02 | 0.24 | -2.6 | 1.5 | 1.48 | 0.2 | Upgrade
|
| EBITDA Margin | 0.03% | 0.47% | -6.05% | 3.89% | 4.13% | 0.56% | Upgrade
|
| D&A For EBITDA | 0.49 | 0.51 | 0.42 | 0.51 | 0.52 | 0.6 | Upgrade
|
| EBIT | -0.48 | -0.27 | -3.02 | 0.99 | 0.96 | -0.4 | Upgrade
|
| EBIT Margin | -1.01% | -0.53% | -7.03% | 2.56% | 2.68% | -1.14% | Upgrade
|
| Effective Tax Rate | - | 170.42% | - | 20.08% | - | - | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.